Skip to main content
Have a personal or library account? Click to login
Polymorphism of Biotransformation Genes and Risk of Relapse in Childhood Acute Leukemia Cover

Polymorphism of Biotransformation Genes and Risk of Relapse in Childhood Acute Leukemia

Open Access
|Oct 2009

References

  1. Wood ME, Philips GK. Hematology/Oncology Secrets. 3rd ed. Philadelphia: Hanley & Belfus Inc., 2003.
  2. Chan KW. Acute lymphoblastic leukemia.2002; 32(2): 40-49.
  3. Ansari M, Krajinovic M. Pharmacogenomics of acute leukemia.2007; 8(7): 817-834.
  4. Seeger K, Adams HP, Buchwald D, Beyermann B, Kremens B, Niemeyer C, Ritter J, Schwabe D, Harms D, Schrappe M, Henze G. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Munster Study Group.1998; 91(5): 1716-1722.
  5. Relling MV, Yanishevski Y, Nemec J, Evans WE, Boyett JM, Behm FG, Pui CH. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia.1998; 12(3): 346-352.
  6. Chupova NV, Samochatova EV, Rudneva AE, Solopova GG, Nasedkina TV, Fedorova OE, Glotov AS, Zemliakova VV, Krynetski EYu, Krynetskaia NF, Ribeiro RC, Evans WE, Rumyantsev AG. Genetic polymorphism of thiopurine-S-methyltransferase and treatment of childhood acute lymphoblastic leukemia.(in Russian with English abstract) 2005; 6: 3-8.
  7. Gra OA, Glotov AS, Nikitin EA, Glotov OS, Kuznetsova VE, Chudinov AV, Sudarikov AB, Nasedkina TV. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.2008; 83(4): 279-287.
  8. Gra OA, Glotov AS, Kozhekbaeva ZhM, Makarova OV, Nasedkina TV. Genetic polymorphism of GST, NAT2, and MTRR and susceptibility to childhood acute leukemia.2008; 42(2): 187-197.
  9. Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate.2004; 96(2): 134-144.
  10. Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, Welte K, Ludwig WD, Bartram CR, Zanger UM, Eichelbaum M, Schrappe M, Schwab M. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.2005; 293(12): 1485-1489.
  11. Krajinovic M, Richer C, Sinnett H, Labuda D, Sinnett D. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia.2000; 9(6): 557-562.
  12. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms.1999; 93(5): 1496-1501.
  13. Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, Lange BJ, Felix CA. Low NAD(P)H: quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.2002; 100(13): 4590-4593.
  14. Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms.1999; 10(5): 481-487.
  15. Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, Hibi S, Todo S, Imashuku S. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.2003; 88(11): 1238-1244.
  16. Krajinovic M, Labuda D, Mathonnet G, Labuda M, Moghrabi A, Champagne J, Sinnett D. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.2002; 8(3): 802-810.
  17. Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH, Sandlund JT, Rubnitz J, Ribeiro R, Campana D, Pui CH, Evans WE, Relling MV. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.2005; 105(12): 4752-4758.
  18. Stanulla M, Schrappe M, Brechlin AM, Zimmermann M, Welte K. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study.2000; 95(4): 1222-1228.
  19. Voso MT, D'Alo F, Gumiero D, Guidi F, Hohaus S, Leone G. The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia.2005; 90(7): 982-984.
  20. Anderer G, Schrappe M, Brechlin AM, Lauten M, Muti P, Welte K, Stanulla M. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukemia.2000; 10(8): 715-726.
  21. Glotov AS, Nasedkina TV, Ivashchenko TE, Iurasov RA, Surzhikov SA, Pan'kov SV, Chudinov AV, Baranov VS, Zasedatelev AS. Biochip development for polymorphism analysis in biotransformation system genes.2005; 39(3): 403-412.
  22. Nasedkina TV, Fedorova OE, Glotov AS, Chupova NV, Samochatova EV, Maiorova OA, Zemlyakova VV, Roudneva AE, Chudinov AV, Yurasov RA, Kozhekbaeva JM, Barsky VE, Krynetskiy EY, Krynetskaia NF, Cheng C, Ribeiro RC, Evans WE, Roumyantsev AG, Zasedatelev AS. Rapid genotyping of common deficient thiopurine Smethyltransferase alleles using the DNA-microchip technique.2006; 14(9): 991-998.
  23. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Warrenton, VA, USA, November 1997.2000; 1(1): 53-66.
  24. Surzhikov SA, Timofeev EN, Chernov BK, Golova JB, Mirzabekov AD. Advanced method for oligonucleotide deprotection.2000; 28(8):E29.
  25. Rubina AY, Pan'kov SV, Dementieva EI, Pen'kov DN, Butygin AV, Vasiliskov VA, Chudinov AV, Mikheikin AL, Mikhailovich VM, Mirzabekov AD. Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production.2004; 325(1): 92-106.
  26. Celander M, Weisbrod R, Stegeman JJ. Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture.1997; 232(3): 749-753.
  27. Tew KD. Glutathione-associated enzymes in anticancer drug resistance.1994; 54(16): 4313-4320.
  28. Yuan ZM, Smith PB, Brundrett RB, Colvin M, Fenselau C. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.1991; 19(3): 625-629.
  29. Vester U, Kranz B, Zimmermann S, Buscher R, Hoyer PF. The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases- M1 and -P1.2005; 20(4): 478-481.
  30. Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ. Metabolism and transport of oxazaphosphorines and the clinical implications.2005; 37(4): 611-703.
  31. Papageorgiou G, Iliadis S, Botsoglou N, Dioudis C, Goulas A, Fletouris D, Dimitriadou-Vafiadou A. Lipid peroxidation of rat myocardial tissue following daunomycin administration.1998; 126(2): 83-91.
  32. Autrup JL, Hokland P, Pedersen L, Autrup H. Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia.2002; 438(1-2): 15-18.
  33. Pompeo F, Brooke E, Kawamura A, Mushtaq A, Sim E. The pharmacogenetics of NAT: structural aspects.2002; 3(1): 19-30.
  34. Goldenkova-Pavlova IV, Bruskin SA, Abdeev RM, Markarova EV, Bigvava SG, Radkevich LA, Kozhekbaeva ZhM, Glotov AS, Gra OA, Zasedatelev AS, Nasedkina TV, Kurdanov KhA, Piruzian ES. Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping.2006; 42(8): 1143-1150.
  35. Kozhekbaeva ZhM, Glotov AS, Gra OA, Golden-kova-Pavlova IV, Bruskin SA, Agafonova EE, Markarova EV, Abdeev RM, Korsunskaia IM, Piruzian AL, Barskii VE, Zasedatelev AS, Nasedkin TV. Identification of functionally significant mutations in NAT2 gene using biological microchips.2007; 41(4): 725-733.
  36. Leff MA, Fretland AJ, Doll MA, Hein DW. Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype.1999; 274(49): 34519-34522.
  37. Hein DW. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.2006; 25(11): 1649-1658.
  38. Borlak J, Reamon-Buettner SM. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.2006; 7: 58.
  39. Chiou HL, Wu MF, Chien WP, Cheng YW, Wong RH, Chen CY, Lin TS, Lee H. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan.2005; 223(1): 93-101.
  40. Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism.1997; 37: 269-296.
  41. Acar H, Caliskan U, Demirel S, Largaespada DA. Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukemia (ALL) patients: detection by micronucleus and FISH techniques.2001; 21(5): 341-347.
  42. Emoto Y, Kisaki H, Manome Y, Kharbanda S, Kufe D. Activation of protein kinase Cδ in human myeloid leukemia cells treated with 1-β-Darabinofuranosylcytosine.1996; 87(5): 1990-1996.
  43. Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.1995; 89(2): 364-372.
  44. Schroeder H, Garwicz S, Kristinsson J, Siimes MA, Wesenberg F, Gustafsson G. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).1995; 25(5): 372-378.
  45. Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR, Broadfield ZJ, Harris RL, Taylor KE, Gibson BE, Hann IM, Hill FG, Kinsey SE, Eden TO, Mitchell CD, Harrison CJ. Outcome heterogeneity in childhood highhyperdiploid acute lymphoblastic leukemia.2003; 102(8): 2756-2762.
DOI: https://doi.org/10.2478/v10034-009-0008-6 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Language: English
Page range: 21 - 35
Published on: Oct 9, 2009
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services

© 2009 O Gra, Zh Kozhekbaeva, O Makarova, E Samochatova, T Nasedkina, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.